Clear Street’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,000
Closed -$1.54M 1328
2023
Q2
$1.54M Buy
5,000
+4,983
+29,312% +$1.53M 0.02% 235
2023
Q1
$5.27K Buy
+17
New +$5.13K ﹤0.01% 646
2022
Q4
Hold
0
1180
2022
Q1
Sell
-309
Closed -$89K 485
2021
Q4
$89K Buy
+309
New +$90.1K ﹤0.01% 73

Other funds holding XAGE

Clear Street's XAGE Position: Q3 2023 in Review

Clear Street sold out of Longevity Health Holdings, Inc. Common Stock (XAGE) in Q3 2023, closing a stake of 5,000 shares — an estimated $1.54M sold.

Clear Street first reported a position in XAGE in Q4 2021 and held it in 3 quarters. The position peaked at $1.54M in Q2 2023. 14 funds tracked by Wall St. Rank hold XAGE as of Q3 2023.

  • Clear Street reported no remaining Longevity Health Holdings, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Clear Street sold 5,000 Longevity Health Holdings, Inc. Common Stock shares in Q3 2023, an estimated $1.54M.
  • Clear Street first reported a position in Longevity Health Holdings, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • Clear Street's Longevity Health Holdings, Inc. Common Stock position peaked at $1.54M in Q2 2023.
  • 14 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q3 2023.

Based on Clear Street's 13F filing for Q3 2023, filed 13 Nov 2023.